Ipriflavone Bone Loss Prevention Benefits Unsupported - JAMA Study
This article was originally published in The Tan Sheet
Executive Summary
Ipriflavone is ineffective in preventing reductions in bone mineral density or affecting bone metabolism and may be less safe than prescription drugs because it decreases white blood cells, European researchers report in the March 21 Journal of the American Medical Association.